---
schema_version: "secwatch.filing_event.v1"
accession: "0001171843-21-007914"
form_type: "8-K"
ticker: "ANIK"
cik: "0000898437"
company_name: "Anika Therapeutics, Inc."
filed_at: "2021-11-15T23:59:59+00:00"
generated_at: "2026-06-28T08:51:11.969158+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Anika Therapeutics enters $75M senior revolving credit facility maturing 2026

## Summary
- Third Amendment to Credit Agreement increases revolving line to $75M, expandable to $150M.
- Maturity date extended to November 12, 2026; interest at BSBY + 0.25%-1.00%.
- Amended agreement governs leverage and interest coverage covenants; first-priority lien on assets.
- Bank of America serves as administrative agent; new lenders join the facility.

## SEC filing metadata
- accession: 0001171843-21-007914
- form_type: 8-K
- ticker: ANIK
- cik: 0000898437
- company_name: Anika Therapeutics, Inc.
- filed_at: 2021-11-15T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 2.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/898437/000117184321007914/0001171843-21-007914-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/898437/000117184321007914/f8k_111521.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001171843-21-007914
- JSON: https://secwatch.observer/filing/0001171843-21-007914.json
- Plain text: https://secwatch.observer/filing/0001171843-21-007914.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.